Skip to main content
Top
Published in: Journal of Cachexia, Sarcopenia and Muscle 2/2010

Open Access 01-12-2010 | Original Article

Cancer-related fatigue: the impact of skeletal muscle mass and strength in patients with advanced cancer

Authors: Robert D. Kilgour, Antonio Vigano, Barbara Trutschnigg, Laura Hornby, Enriqueta Lucar, Simon L. Bacon, José A. Morais

Published in: Journal of Cachexia, Sarcopenia and Muscle | Issue 2/2010

Login to get access

Abstract

Background

Although exertional fatigue is directly and negatively related to skeletal muscle mass and strength, it is currently unknown if these variables are associated with cancer-related fatigue (CRF). Therefore, the purpose of this study was to determine if CRF is associated with measures of appendicular lean muscle mass and strength in advanced cancer patients (ACP).

Methods and results

Eighty-four patients (48 men, 36 women aged 61.6 ± 13.2 year) newly diagnosed (≤6 months) with inoperable (Stages III–IV) gastrointestinal or non-small cell lung cancer participated in this study. All patients completed the Brief Fatigue Inventory (BFI). Handgrip (HGS) and quadriceps (QS) strength were assessed using isometric and isokinetic dynamometry, respectively. Skeletal muscle mass index (SMMI) was calculated from the appendicular lean mass measured via dual-energy X-ray absorptiometry divided by body height squared. Univariate analysis showed BFI to be significantly associated with body mass index, weight loss, anemia, hypoalbuminemia, activity level, pain, depression, and sarcopenia along with SMMI, HGS, and QS. HGS (r = −0.34; p = 0.018), QS (r = −0.39; p = 0.024), and SMMI (r = −0.60; p < 0.001) were negatively correlated with BFI total scores in men but not in women. When adjusted for sex, age, diagnosis, survival, along with the above characteristics, multivariate analyses showed that BFI scores were negatively associated with HGS (B = −0.90; 95% CI −1.5:−0.3), QS (−0.2; −0.3:−0.01), and SMMI (−7.5; −13.0:−2.0). There was a significant sex × SMMI interaction (10.8; 1.2:20.5), where BFI decreased with increasing SMMI in men, but did not change with SMMI in women.

Conclusion

These results suggest that in ACP, CRF is related to muscle mass and strength, which may provide targets for future interventions.
Literature
1.
go back to reference Ahlberg K, Ekman T, Gaston-Johansson F, Mock V. Assessment and management of cancer-related fatigue in adults. Lancet. 2003;362:640–50.CrossRefPubMed Ahlberg K, Ekman T, Gaston-Johansson F, Mock V. Assessment and management of cancer-related fatigue in adults. Lancet. 2003;362:640–50.CrossRefPubMed
2.
go back to reference Khalid U, Spiro A, Baldwin C, Sharma B, McGough C, Norman AR, et al. Symptoms and weight loss in patients with gastrointestinal and lung cancer at presentation. Support Care Cancer. 2007;15:39–45.CrossRefPubMed Khalid U, Spiro A, Baldwin C, Sharma B, McGough C, Norman AR, et al. Symptoms and weight loss in patients with gastrointestinal and lung cancer at presentation. Support Care Cancer. 2007;15:39–45.CrossRefPubMed
3.
go back to reference Yennurajalingam S, Palmer J, Zhang T, Poulter V, Bruera E. Association between fatigue and other cancer-related symptoms in patients with advanced cancer. Support Care Cancer. 2008;16:1125–30.CrossRefPubMed Yennurajalingam S, Palmer J, Zhang T, Poulter V, Bruera E. Association between fatigue and other cancer-related symptoms in patients with advanced cancer. Support Care Cancer. 2008;16:1125–30.CrossRefPubMed
4.
go back to reference Berglund G, Bolund C, Fornander T, et al. Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients. Eur J Cancer. 1991;27:1075–81.CrossRefPubMed Berglund G, Bolund C, Fornander T, et al. Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients. Eur J Cancer. 1991;27:1075–81.CrossRefPubMed
5.
go back to reference Jager A, Sleijfer S, van der Rijt C. The pathogenesis of cancer related fatigue: could increased activity of pro-inflammatory cytokines be the common denominator? Eur J Cancer. 2008;44:175–81.CrossRefPubMed Jager A, Sleijfer S, van der Rijt C. The pathogenesis of cancer related fatigue: could increased activity of pro-inflammatory cytokines be the common denominator? Eur J Cancer. 2008;44:175–81.CrossRefPubMed
6.
go back to reference Fearon K, Voss A, Hustead D. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr. 2006;83:1345–50.PubMed Fearon K, Voss A, Hustead D. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr. 2006;83:1345–50.PubMed
7.
go back to reference Michalaki V, Syrigos K, Charles P, et al. Serum levels of IL-6 and TNF-α correlate with clinicopathological features and patient survival in patients with prostate cancer. Br J Cancer. 2004;90:2312–6.PubMed Michalaki V, Syrigos K, Charles P, et al. Serum levels of IL-6 and TNF-α correlate with clinicopathological features and patient survival in patients with prostate cancer. Br J Cancer. 2004;90:2312–6.PubMed
8.
go back to reference Demetri G, Kris M, Wade J, Degos L, Cella D. Quality of life benefit in chemotherapy patients treated with epoeitin alpha is independent of disease response or tumor type: results from a prospective Community Oncology study. J Clin Oncol. 1998;16:3412–25.PubMed Demetri G, Kris M, Wade J, Degos L, Cella D. Quality of life benefit in chemotherapy patients treated with epoeitin alpha is independent of disease response or tumor type: results from a prospective Community Oncology study. J Clin Oncol. 1998;16:3412–25.PubMed
9.
go back to reference Shafqat A, Einhorn L, Hanna N, Sledge G, Hanna A, Juliar B, et al. Screening for fatigue and laboratory correlates in cancer patients undergoing treatment. Ann Oncol. 2005;16:1545–50.CrossRefPubMed Shafqat A, Einhorn L, Hanna N, Sledge G, Hanna A, Juliar B, et al. Screening for fatigue and laboratory correlates in cancer patients undergoing treatment. Ann Oncol. 2005;16:1545–50.CrossRefPubMed
10.
go back to reference Evans W, Morley J, Argiles J, Bales C, Baracos V, et al. Cachexia: a new definition. Clin Nutr. 2008;27:793–9.CrossRefPubMed Evans W, Morley J, Argiles J, Bales C, Baracos V, et al. Cachexia: a new definition. Clin Nutr. 2008;27:793–9.CrossRefPubMed
11.
go back to reference Stone P, Richards M, A’Hern R, Hardy J. A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol. 2000;11:561–7.CrossRefPubMed Stone P, Richards M, A’Hern R, Hardy J. A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol. 2000;11:561–7.CrossRefPubMed
12.
go back to reference Stone P, Hardy J, Broadley K, Tookman AJ, Kurowska A, A’Hern R. Fatigue in advanced cancer: a prospective controlled cross-sectional study. Br J Cancer. 1999;79:1479–86.CrossRefPubMed Stone P, Hardy J, Broadley K, Tookman AJ, Kurowska A, A’Hern R. Fatigue in advanced cancer: a prospective controlled cross-sectional study. Br J Cancer. 1999;79:1479–86.CrossRefPubMed
13.
go back to reference Winters-Stone K, Bennett J, Nail L, Schwartz A. Strength, physical activity, and age predict fatigue in older breast cancer survivors. Oncol Nurse Forum. 2008;35:815–21.CrossRef Winters-Stone K, Bennett J, Nail L, Schwartz A. Strength, physical activity, and age predict fatigue in older breast cancer survivors. Oncol Nurse Forum. 2008;35:815–21.CrossRef
14.
go back to reference Olson K, Turner A, Courneya K, Field C, Man G, Cree M, et al. Possible links between behavioral and physiological indices of tiredness, fatigue, and exhaustion in advanced cancer. Support Cancer Care. 2008;16:241–9.CrossRef Olson K, Turner A, Courneya K, Field C, Man G, Cree M, et al. Possible links between behavioral and physiological indices of tiredness, fatigue, and exhaustion in advanced cancer. Support Cancer Care. 2008;16:241–9.CrossRef
15.
go back to reference Dimeo F, Stieglitz R, Novelli-Fischer U, Fetscher S, Keul J. Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy. Cancer. 1999;85:2273–7.CrossRefPubMed Dimeo F, Stieglitz R, Novelli-Fischer U, Fetscher S, Keul J. Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy. Cancer. 1999;85:2273–7.CrossRefPubMed
16.
go back to reference Dimeo F, Schwartz S, Wesel N, Voigt A, Thiel E. Effects of an endurance and resistance exercise program on persistent cancer-related fatigue after treatment. Ann Oncol. 2008;19:1495–9.CrossRefPubMed Dimeo F, Schwartz S, Wesel N, Voigt A, Thiel E. Effects of an endurance and resistance exercise program on persistent cancer-related fatigue after treatment. Ann Oncol. 2008;19:1495–9.CrossRefPubMed
17.
go back to reference Segal R, Reid R, Courneya K, Malone S, Parliament M, Scott C, et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol. 2003;21:1653–9.CrossRefPubMed Segal R, Reid R, Courneya K, Malone S, Parliament M, Scott C, et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol. 2003;21:1653–9.CrossRefPubMed
18.
go back to reference Convertino V, Bloomfield S, Greenleaf J. An overview of the issues: physiological effects of bed rest and restricted physical activity. Med Sci Sports Exerc. 1997;29:187–90.PubMed Convertino V, Bloomfield S, Greenleaf J. An overview of the issues: physiological effects of bed rest and restricted physical activity. Med Sci Sports Exerc. 1997;29:187–90.PubMed
19.
go back to reference Strasser F. Diagnostic criteria of cachexia and their assessment: decreased muscle strength and fatigue. Curr Opin Clin Nutr Metab Care. 2008;11:417–21.CrossRefPubMed Strasser F. Diagnostic criteria of cachexia and their assessment: decreased muscle strength and fatigue. Curr Opin Clin Nutr Metab Care. 2008;11:417–21.CrossRefPubMed
20.
go back to reference Heymsfield SB, Smith R, Aulet M, Bensen B, Lichtman S, Wang J, et al. Appendicular skeletal mass: measurement by dual photon absorptiometry. Am J Clin Nutr. 1990;52:214–8.PubMed Heymsfield SB, Smith R, Aulet M, Bensen B, Lichtman S, Wang J, et al. Appendicular skeletal mass: measurement by dual photon absorptiometry. Am J Clin Nutr. 1990;52:214–8.PubMed
21.
go back to reference Innes E. Handgrip strength testing: a review of the literature. Aust Occup Ther J. 1999;46:120–40.CrossRef Innes E. Handgrip strength testing: a review of the literature. Aust Occup Ther J. 1999;46:120–40.CrossRef
22.
go back to reference Trutschnigg B, Kilgour RD, Reinglas J, Rosenthall L, Hornby L, Morais JA, et al. Precision and reliability of strength (Jamar vs. Biodex handgrip) and body composition (dual-energy X-ray absorptiometry vs. bioimpedance analysis) measurements in advanced cancer patients. Appl Physiol Nutr Metab. 2008;33:1232–9.CrossRefPubMed Trutschnigg B, Kilgour RD, Reinglas J, Rosenthall L, Hornby L, Morais JA, et al. Precision and reliability of strength (Jamar vs. Biodex handgrip) and body composition (dual-energy X-ray absorptiometry vs. bioimpedance analysis) measurements in advanced cancer patients. Appl Physiol Nutr Metab. 2008;33:1232–9.CrossRefPubMed
23.
go back to reference Brown DJ, McMillan DC, Milroy R. The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer. Cancer. 2005;103:377–82.CrossRefPubMed Brown DJ, McMillan DC, Milroy R. The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer. Cancer. 2005;103:377–82.CrossRefPubMed
24.
go back to reference Fearon KC, Voss AC, Hustead DS, Cancer Cachexia Study Group. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr. 2006;83:1345–50.PubMed Fearon KC, Voss AC, Hustead DS, Cancer Cachexia Study Group. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr. 2006;83:1345–50.PubMed
25.
go back to reference Drouin JM, Valovich-McLeod TC, Shultz SJ, Gansneder BM, Perrin DH. Reliability and validity of the Biodex system 3 pro isokinetic dynamometer velocity, torque and position measurements. Eur J Appl Physiol. 2004;91:22–9.CrossRefPubMed Drouin JM, Valovich-McLeod TC, Shultz SJ, Gansneder BM, Perrin DH. Reliability and validity of the Biodex system 3 pro isokinetic dynamometer velocity, torque and position measurements. Eur J Appl Physiol. 2004;91:22–9.CrossRefPubMed
26.
27.
go back to reference Weber M-A, Krakowski-Roosen H, Schröder L, Kinscherf R, Krix M, Kopp-Schneider A, et al. Morphology, metabolism, microcirculation, and strength of skeletal muscles in cancer-related cachexia. Acta Oncol. 2009;48:116–24.CrossRefPubMed Weber M-A, Krakowski-Roosen H, Schröder L, Kinscherf R, Krix M, Kopp-Schneider A, et al. Morphology, metabolism, microcirculation, and strength of skeletal muscles in cancer-related cachexia. Acta Oncol. 2009;48:116–24.CrossRefPubMed
28.
go back to reference Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, et al. The rapid assessment of fatigue severity in cancer patients. Cancer. 1999;85:1186–96.CrossRefPubMed Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, et al. The rapid assessment of fatigue severity in cancer patients. Cancer. 1999;85:1186–96.CrossRefPubMed
29.
go back to reference Chang YJ, Lee JS, Lee CG, Lee WS, Lee KS, Bang SM, et al. Assessment of clinical relevant fatigue level in cancer. Support Care Cancer. 2007;15:891–6.CrossRefPubMed Chang YJ, Lee JS, Lee CG, Lee WS, Lee KS, Bang SM, et al. Assessment of clinical relevant fatigue level in cancer. Support Care Cancer. 2007;15:891–6.CrossRefPubMed
30.
go back to reference Yennurajalingam S, Bruera E. Fatigue and asthenia. In Hanks G, Cherny NI, Christakis NA, Fallon M, Kaasa S, Portenoy RK, editors. Oxford Textbook of Palliative Medicine 4th edition, Oxford; 2010. Yennurajalingam S, Bruera E. Fatigue and asthenia. In Hanks G, Cherny NI, Christakis NA, Fallon M, Kaasa S, Portenoy RK, editors. Oxford Textbook of Palliative Medicine 4th edition, Oxford; 2010.
31.
go back to reference Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991;7:6–9.PubMed Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991;7:6–9.PubMed
32.
go back to reference Charlson ME, Ales KA, Pompei P, Mackenzie CR. A new method of classification of prognostic comorbidity for longitudinal studies: development and validation. J Chron Dis. 1987;40:373–83.CrossRefPubMed Charlson ME, Ales KA, Pompei P, Mackenzie CR. A new method of classification of prognostic comorbidity for longitudinal studies: development and validation. J Chron Dis. 1987;40:373–83.CrossRefPubMed
33.
go back to reference Zubrod CG, Sheiderman MA, Frei E, et al. Appraisal of methods for the study of chemotherapy in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chron Dis. 1960;11:7–33.CrossRef Zubrod CG, Sheiderman MA, Frei E, et al. Appraisal of methods for the study of chemotherapy in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chron Dis. 1960;11:7–33.CrossRef
34.
go back to reference Modlesky C, Bickel C, Slade J, Meyer RA, Cureton KJ, Dudley GA. Assessment of skeletal muscle mass in men with spinal cord injury using dual-energy X-ray absorptiometry and magnetic resonance imaging. J Appl Physiol. 2004;96:561–5.CrossRefPubMed Modlesky C, Bickel C, Slade J, Meyer RA, Cureton KJ, Dudley GA. Assessment of skeletal muscle mass in men with spinal cord injury using dual-energy X-ray absorptiometry and magnetic resonance imaging. J Appl Physiol. 2004;96:561–5.CrossRefPubMed
35.
go back to reference Shih R, Wang Z, Heo M, Wang W, Heymsfield SB. Lower limb skeletal muscle mass: development of dual-energy X-ray absorptiometry prediction model. J Appl Physiol. 2000;89:1380–6.PubMed Shih R, Wang Z, Heo M, Wang W, Heymsfield SB. Lower limb skeletal muscle mass: development of dual-energy X-ray absorptiometry prediction model. J Appl Physiol. 2000;89:1380–6.PubMed
36.
go back to reference Lynch NA, Metter EJ, Lindle RS, Fozard JL, Tobin JD, Roy TA, et al. Muscle quality. I. Age-associated differences between arm and leg muscle groups. J Appl Physiol. 1999;86:188–94.PubMed Lynch NA, Metter EJ, Lindle RS, Fozard JL, Tobin JD, Roy TA, et al. Muscle quality. I. Age-associated differences between arm and leg muscle groups. J Appl Physiol. 1999;86:188–94.PubMed
37.
go back to reference Newman AB, Kupelian V, Visser M, Simonsick EM, Goodpaster BH, Kritchevsky SB, et al. Strength, but not muscle mass, is associated with mortality in the Health, Aging and Body Composition Study cohort. J Gerontol Med Sci. 2006;61A:72–7. Newman AB, Kupelian V, Visser M, Simonsick EM, Goodpaster BH, Kritchevsky SB, et al. Strength, but not muscle mass, is associated with mortality in the Health, Aging and Body Composition Study cohort. J Gerontol Med Sci. 2006;61A:72–7.
38.
go back to reference Goodpaster B, Carlson C, Visser M, Kelley DE, Scherzinger A, Harris TB, et al. Attenuation of skeletal muscle and strength in the elderly: the Health ABC Study. J Appl Physiol. 2001;90:2157–65.PubMed Goodpaster B, Carlson C, Visser M, Kelley DE, Scherzinger A, Harris TB, et al. Attenuation of skeletal muscle and strength in the elderly: the Health ABC Study. J Appl Physiol. 2001;90:2157–65.PubMed
39.
go back to reference Davis M, Walsh D. Mechanisms of fatigue. J Support Oncol. 2010;8:164–74.PubMed Davis M, Walsh D. Mechanisms of fatigue. J Support Oncol. 2010;8:164–74.PubMed
40.
go back to reference von Haehling S, Morley JE, Coats AJ, Anker SD. Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle. J Cachexia Sarcopenia Muscle. 2010. doi:10.1007/s13539-010-0003-5. von Haehling S, Morley JE, Coats AJ, Anker SD. Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle. J Cachexia Sarcopenia Muscle. 2010. doi:10.​1007/​s13539-010-0003-5.
41.
go back to reference Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147:755–63.PubMed Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147:755–63.PubMed
Metadata
Title
Cancer-related fatigue: the impact of skeletal muscle mass and strength in patients with advanced cancer
Authors
Robert D. Kilgour
Antonio Vigano
Barbara Trutschnigg
Laura Hornby
Enriqueta Lucar
Simon L. Bacon
José A. Morais
Publication date
01-12-2010
Publisher
Springer-Verlag
Published in
Journal of Cachexia, Sarcopenia and Muscle / Issue 2/2010
Print ISSN: 2190-5991
Electronic ISSN: 2190-6009
DOI
https://doi.org/10.1007/s13539-010-0016-0

Other articles of this Issue 2/2010

Journal of Cachexia, Sarcopenia and Muscle 2/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.